Allos Therapeutics (ALTH) roars to a 27.9% gain premarket up to $1.85 a share after Spectrum...

|About: Allos Therapeutics, Inc. (ALTH)|By:, SA News Editor

Allos Therapeutics (ALTH) roars to a 27.9% gain premarket up to $1.85 a share after Spectrum Pharmaceuticals (SPPI) agrees to buy the company. The trading price falls in the range between the offering price of $1.82/share and the $1.93-a-share value of the deal with kickers. Shares of SPPI -9.9% premarket, reeling from a negative results from a trial on apaziquone.